Drug testing in equestrian competition aims to prevent performance enhancement and ensure horses compete without masking pain. The welfare implications of medication policy are complex and contested.
The medication policy debate in equestrian sport is fundamentally a welfare debate. Allowing pain-masking medications enables horses with treatable or manageable conditions to compete when they should be resting, potentially converting a short-term welfare problem into a permanent injury. Prohibiting therapeutic medications entirely may mean horses with well-managed chronic conditions cannot compete despite being genuinely comfortable and sound. The welfare-optimal framework requires accurate lameness examination to assess genuine soundness independent of medication status, clear evidence-based thresholds, and culture change away from competing horses that require pain management to pass pre-competition examinations. The jog test, when conducted rigorously and by independent veterinarians, remains the best direct welfare assessment tool at competitions.